Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.
Campbell NR. et al, (2021), Dev Cell, 56, 2808 - 2825.e10
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8+ T cell clone size and cytotoxicity.
Watson RA. et al, (2021), Sci Immunol, 6
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
Sasson SC. et al, (2021), Gastroenterology, 161, 1229 - 1244.e9
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.
Ye W. et al, (2021), Br J Cancer, 124, 1661 - 1669
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
SIVAKUMAR S. et al, (2021), Molecular Biomarkers and Precision Medicine for Pancreatic, Liver and Biliary Tract Cancers
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study
Dalle S. et al, (2021), BMC Cancer
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study
Dalle S. et al, (2021), BMC Cancer
Tumour gene expression signature in primary melanoma predicts long-term outcomes
Garg M. et al, (2021), Nature Communications
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.
Middleton MR. et al, (2020), Clin Cancer Res, 26, 5869 - 5878
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Ascierto PA. et al, (2020), Lancet Oncol, 21, 1465 - 1477
sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.
Fane ME. et al, (2020), Clin Cancer Res, 26, 5709 - 5719
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives.
Middleton MR. et al, (2020), Br J Cancer, 123, 885 - 897
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Cheung VTF. et al, (2020), Br J Cancer, 123, 207 - 215
ctDNA monitoring using patient-specific sequencing and integration of variant reads.
Wan JCM. et al, (2020), Sci Transl Med, 12
Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma.
Hemstock M. et al, (2020), Eur J Cancer, 132, 176 - 186
Tuning transcription factor availability through acetylation-mediated genomic redistribution
GODING C., (2020), Molecular Cell
Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'.
Peris K. et al, (2020), Eur J Cancer, 131, 100 - 103
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ. et al, (2020), Eur J Cancer, 128, 60 - 82